These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1352574)

  • 21. Microglia in prion diseases.
    Aguzzi A; Zhu C
    J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered Ca
    Llorens F; Thüne K; Sikorska B; Schmitz M; Tahir W; Fernández-Borges N; Cramm M; Gotzmann N; Carmona M; Streichenberger N; Michel U; Zafar S; Schuetz AL; Rajput A; Andréoletti O; Bonn S; Fischer A; Liberski PP; Torres JM; Ferrer I; Zerr I
    Acta Neuropathol Commun; 2017 Apr; 5(1):35. PubMed ID: 28449707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cells release prions in association with exosomes.
    Fevrier B; Vilette D; Archer F; Loew D; Faigle W; Vidal M; Laude H; Raposo G
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9683-8. PubMed ID: 15210972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CNS pathogenesis of prion diseases.
    Brandner S
    Br Med Bull; 2003; 66():131-9. PubMed ID: 14522855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.
    Price DL; Borchelt DR; Sisodia SS
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6381-4. PubMed ID: 8101988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
    Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
    PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow Cytometric Detection of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular pathogenesis in prion diseases.
    Crozet C; Beranger F; Lehmann S
    Vet Res; 2008; 39(4):44. PubMed ID: 18413130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenetic investigations of prion diseases of humans and animals.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):239-54. PubMed ID: 8097053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitin-protein conjugates: clinical and experimental findings.
    Doherty FJ; Laszlo L; Lowe J; Lennox G; Landon M; Mayer RJ
    Revis Biol Celular; 1989; 20():255-73. PubMed ID: 2561545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of prion pathogenesis.
    Aguzzi A; Sigurdson C; Heikenwaelder M
    Annu Rev Pathol; 2008; 3():11-40. PubMed ID: 18233951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain Disorders Due to Lysosomal Dysfunction.
    Fraldi A; Klein AD; Medina DL; Settembre C
    Annu Rev Neurosci; 2016 Jul; 39():277-95. PubMed ID: 27090953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scrapie-specific neuronal lesions are independent of neuronal PrP expression.
    Jeffrey M; Goodsir CM; Race RE; Chesebro B
    Ann Neurol; 2004 Jun; 55(6):781-92. PubMed ID: 15174012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prions activate a p38 MAPK synaptotoxic signaling pathway.
    Fang C; Wu B; Le NTT; Imberdis T; Mercer RCC; Harris DA
    PLoS Pathog; 2018 Sep; 14(9):e1007283. PubMed ID: 30235355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional mapping of prion proteins in brain.
    Taraboulos A; Jendroska K; Serban D; Yang SL; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7620-4. PubMed ID: 1354357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain.
    Arnold JE; Tipler C; Laszlo L; Hope J; Landon M; Mayer RJ
    J Pathol; 1995 Aug; 176(4):403-11. PubMed ID: 7562256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.